Aerie Pharmaceuticals Inc

STIFEL FINANCIAL CORP

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

45,665

Value ($000)

691

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	691	0.0%	45,665	9/30/2022
2022 Q2	8/15/2022	1,418	0.0%	189,026	6/30/2022
2022 Q1	5/13/2022	1,675	0.0%	184,014	3/31/2022
2021 Q4	2/14/2022	913	0.0%	130,110	12/31/2021
2021 Q3	11/15/2021	1,164	0.0%	102,126	9/30/2021
2021 Q2	8/13/2021	1,305	0.0%	81,539	6/30/2021
2021 Q1	5/14/2021	1,526	0.0%	85,379	3/31/2021
2020 Q4	2/12/2021	1,290	0.0%	95,494	12/31/2020
2020 Q3	11/16/2020	1,856	0.0%	157,730	9/30/2020
2020 Q2	8/14/2020	1,466	0.0%	99,303	6/30/2020
2020 Q1	5/14/2020	1,157	0.0%	85,887	3/31/2020
2019 Q4	2/13/2020	3,080	0.0%	128,256	12/31/2019